Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 7/2009

01-07-2009 | CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER

AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference

Authors: Jean-Nicolas Vauthey, MD, Elijah Dixon, MD

Published in: Annals of Surgical Oncology | Issue 7/2009

Login to get access

Excerpt

On January 24, 2008, the American Hepato-Pancreato-Biliary Association convened a Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer. The conference was cosponsored by the Society of Surgical Oncology, the Society for Surgery of the Alimentary Tract, The University of Texas M. D. Anderson Cancer Center, and the Gastrointestinal Symposium Steering Committee. The goals of this conference were to define resectable and borderline resectable pancreatic cancer and to review the indications and contraindications for surgery, neoadjuvant therapy, and adjuvant therapy for these lesions. The meeting took place over 1 day and was divided into three sessions addressing (1) pretreatment assessment, (2) surgical treatment, and (3) combined-modality treatment. …
Literature
1.
Vauthey JN, Choti MA, Helton WS. AHPBA/SSO/SSAT consensus conference on hepatic colorectal metastases: rationale and overview of the conference. January 25, 2006. Ann Surg Oncol. 2006;13:1259–60.PubMedCrossRef
Metadata
Title
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference
Authors
Jean-Nicolas Vauthey, MD
Elijah Dixon, MD
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0409-5

Other articles of this Issue 7/2009

Annals of Surgical Oncology 7/2009 Go to the issue

Breast Oncology

Clinicopathological Factors and Nomograms Predicting Nonsentinel Lymph Node Metastases After Neoadjuvant Chemotherapy in Breast Cancer Patients

Bone and Soft Tissue Sarcomas

Valgus Ankle Deformity After Vascularized Fibular Reconstruction for Oncologic Disease

Translational Research and Biomarkers

Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin

Hepatobiliary and Pancreatic Tumors

Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy

Breast Oncology

Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?

CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER

Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement